CO6260061A2 - (ciclopropilfenil)feniloxamidas metodo para su produccion y su uso como medicamento - Google Patents
(ciclopropilfenil)feniloxamidas metodo para su produccion y su uso como medicamentoInfo
- Publication number
- CO6260061A2 CO6260061A2 CO10030967A CO10030967A CO6260061A2 CO 6260061 A2 CO6260061 A2 CO 6260061A2 CO 10030967 A CO10030967 A CO 10030967A CO 10030967 A CO10030967 A CO 10030967A CO 6260061 A2 CO6260061 A2 CO 6260061A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- phenyl
- phenyloxamids
- ciclopropilfenil
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Un compuesto de la fórmula Ien donde los significados son R1, R2, R3, R4, R5, de manera independiente entre sí, H, F, CI, Br, CN, CF3, OH, OCF3, OCHF2, SCH3, SCF3, fenilo, Ofenilo, COOH, COO-alquilo (C1-C6), CO-alquilo (C1-C6), alquilo (C1-C6), O-alquilo (C1-C6), OBn, SO2-alquilo (C1-C4), SO3H, SO2NR9R10, NR9R10 o SO2-N-piperidinilo, en donde alquilo y fenilo pueden estar sustituidos una o varias veces con R12;R7, R8, de manera independiente entre sí, H o alquilo (C1 C6); m 0, 1, 2, 3 ó 4; R6 OH, F, CI, Br, CN, OCH3, OCF3, CH3, CF3, alquilo (C1-C6) o O-alquilo (C1-C6), en donde alquilo puede estar sustituido una o más veces con OH, F, CI, Br o CN; R9, R10, de manera independiente entre sí, H, alquilo (C1-C6) o fenilo, donde alquilo puede estar sustituido una o varias veces con F, CI o Br, y fenilo puede estar sustituido una o varias veces con R6; R11 F, CI, Br, CN, OH, O-alquilo (C1-C6), alquilo (C1-C6), alquenilo (C2-C6), alquinilo (C2-C6) o NR9R10; R12 F, CI, Br, CN, OH, O-alquilo (C1-C6), alquilo (C1-C6), alquenilo (C2-C6), alquinilo (C2-C6), NR9R10, COOH, COO-alquilo (C1-C4), SCH3, SCF3, SO2-alquilo (C1-C4), SO3H o SO2NR9R10; y sus sales fisiológicamente toleradas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07291131 | 2007-09-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6260061A2 true CO6260061A2 (es) | 2011-03-22 |
Family
ID=39111440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO10030967A CO6260061A2 (es) | 2007-09-21 | 2010-03-16 | (ciclopropilfenil)feniloxamidas metodo para su produccion y su uso como medicamento |
Country Status (20)
Country | Link |
---|---|
US (1) | US8148375B2 (es) |
EP (1) | EP2203415B1 (es) |
JP (1) | JP2011509239A (es) |
KR (1) | KR20100075444A (es) |
CN (1) | CN101796018A (es) |
AR (1) | AR070753A1 (es) |
AU (1) | AU2008303975B2 (es) |
BR (1) | BRPI0817198A2 (es) |
CA (1) | CA2700025A1 (es) |
CL (1) | CL2008002768A1 (es) |
CO (1) | CO6260061A2 (es) |
IL (1) | IL204556A (es) |
MA (1) | MA31979B1 (es) |
MX (1) | MX2010002419A (es) |
NZ (1) | NZ584050A (es) |
RU (1) | RU2010115747A (es) |
TW (1) | TW200934751A (es) |
UY (1) | UY31351A1 (es) |
WO (1) | WO2009039942A1 (es) |
ZA (1) | ZA201001014B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
BR112013004882A2 (pt) | 2010-08-31 | 2016-05-03 | Snu R&Db Foundation | utilização de reprogramação fetal de agonista ppar delta |
SI2626350T1 (sl) * | 2010-09-22 | 2015-09-30 | Eisai R&D Management Co., Ltd. | Spojina ciklopropana |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014064215A1 (en) | 2012-10-24 | 2014-05-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL |
US9957219B2 (en) | 2013-12-04 | 2018-05-01 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
EP3102198B1 (en) | 2014-02-06 | 2020-08-26 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
WO2016063995A1 (en) | 2014-10-23 | 2016-04-28 | Eisai R&D Management Co., Ltd. | Compositions and methods for treating insomnia |
US10426818B2 (en) | 2015-03-24 | 2019-10-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Method and pharmaceutical composition for use in the treatment of diabetes |
TWI796596B (zh) | 2018-02-13 | 2023-03-21 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
JP7242702B2 (ja) | 2018-04-19 | 2023-03-20 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
EP4234030A3 (en) | 2018-07-13 | 2023-10-18 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
CN112955435A (zh) | 2018-10-24 | 2021-06-11 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
CN109574920B (zh) * | 2018-12-25 | 2022-03-04 | 药大制药有限公司 | 3-腈基-6环丙基吡啶类ido1抑制剂及其用途 |
WO2020149129A1 (ja) * | 2019-01-15 | 2020-07-23 | 株式会社カネカ | 非対称化合物の製造方法 |
MX2021014410A (es) * | 2019-05-31 | 2022-03-17 | Avolynt | Composiciones y métodos para tratar la enfermedad metabólica. |
WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
MX2022014505A (es) | 2020-05-19 | 2022-12-13 | Kallyope Inc | Activadores de la ampk. |
JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ,インク. | Ampkアクチベーター |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6890568B2 (en) * | 1999-05-24 | 2005-05-10 | Grant Pierce | Method for management of blood glucose levels |
EP1395561A1 (en) * | 2001-05-25 | 2004-03-10 | Boehringer Ingelheim Pharmaceuticals Inc. | Carbamate and oxamide compounds as inhibitors of cytokine production |
US20050124667A1 (en) * | 2003-10-30 | 2005-06-09 | Eric Sartori | Oxamide inhibitors of plasminogen activator inhibitor-1 |
-
2008
- 2008-09-04 BR BRPI0817198 patent/BRPI0817198A2/pt not_active IP Right Cessation
- 2008-09-04 MX MX2010002419A patent/MX2010002419A/es not_active Application Discontinuation
- 2008-09-04 NZ NZ584050A patent/NZ584050A/en not_active IP Right Cessation
- 2008-09-04 RU RU2010115747/04A patent/RU2010115747A/ru unknown
- 2008-09-04 EP EP08785814.8A patent/EP2203415B1/de active Active
- 2008-09-04 JP JP2010525226A patent/JP2011509239A/ja not_active Abandoned
- 2008-09-04 CA CA2700025A patent/CA2700025A1/en not_active Abandoned
- 2008-09-04 AU AU2008303975A patent/AU2008303975B2/en not_active Expired - Fee Related
- 2008-09-04 CN CN200880105479A patent/CN101796018A/zh active Pending
- 2008-09-04 WO PCT/EP2008/007217 patent/WO2009039942A1/de active Application Filing
- 2008-09-04 KR KR1020107006033A patent/KR20100075444A/ko not_active Application Discontinuation
- 2008-09-16 CL CL2008002768A patent/CL2008002768A1/es unknown
- 2008-09-18 TW TW097135730A patent/TW200934751A/zh unknown
- 2008-09-18 AR ARP080104057A patent/AR070753A1/es not_active Application Discontinuation
- 2008-09-19 UY UY31351A patent/UY31351A1/es not_active Application Discontinuation
-
2010
- 2010-02-11 ZA ZA201001014A patent/ZA201001014B/xx unknown
- 2010-03-16 IL IL204556A patent/IL204556A/en not_active IP Right Cessation
- 2010-03-16 US US12/724,517 patent/US8148375B2/en not_active Expired - Fee Related
- 2010-03-16 CO CO10030967A patent/CO6260061A2/es not_active Application Discontinuation
- 2010-03-19 MA MA32712A patent/MA31979B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20100261644A1 (en) | 2010-10-14 |
BRPI0817198A2 (pt) | 2015-03-17 |
IL204556A0 (en) | 2010-11-30 |
RU2010115747A (ru) | 2011-10-27 |
EP2203415A1 (de) | 2010-07-07 |
TW200934751A (en) | 2009-08-16 |
CA2700025A1 (en) | 2009-04-02 |
CN101796018A (zh) | 2010-08-04 |
AU2008303975A1 (en) | 2009-04-02 |
MA31979B1 (fr) | 2011-01-03 |
UY31351A1 (es) | 2009-04-30 |
AR070753A1 (es) | 2010-05-05 |
MX2010002419A (es) | 2010-03-30 |
CL2008002768A1 (es) | 2009-03-06 |
WO2009039942A1 (de) | 2009-04-02 |
KR20100075444A (ko) | 2010-07-02 |
JP2011509239A (ja) | 2011-03-24 |
EP2203415B1 (de) | 2016-10-26 |
ZA201001014B (en) | 2010-10-27 |
US8148375B2 (en) | 2012-04-03 |
AU2008303975B2 (en) | 2013-05-16 |
IL204556A (en) | 2013-06-27 |
NZ584050A (en) | 2011-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6260061A2 (es) | (ciclopropilfenil)feniloxamidas metodo para su produccion y su uso como medicamento | |
CO6260062A2 (es) | (carboxilalquilenfenil)feniloxamidas metodo para su produccion y uso de las mismas como medicamentos | |
DOP2015000014A (es) | Derivados de azaadamantano y metodos de uso de los mismos | |
ES2486267T3 (es) | 2-(Fenil 2-fluoro-substituido)-6-amino-5-cloro-4-pirimidinacarboxilatos y su uso como herbicidas | |
CO6300939A2 (es) | Compuestos novedosos que son inhibidores de erk referencia a una solicitud relacionada | |
CR11857A (es) | Compuestos pirazolicos 436 | |
CO6220951A2 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
UY30976A1 (es) | Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones. | |
ECSP109856A (es) | Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842 | |
UY31524A1 (es) | Nuevos compuestos 010 | |
NI201000179A (es) | Pirimidin-5-carboxamidas sustituidas 281 | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
AR061739A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
CY1111830T1 (el) | Παραγωγα πυριδινης ως ρυθμιστες υποδοχεων s1p1/edg1 | |
SV2010003598A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
CR11518A (es) | Compuestos de carbamoilo como inhibidores de dgat1 190 | |
AR058077A1 (es) | Derivados de acidos fenoxiaceticos | |
CL2008000661A1 (es) | Composiciones de sales bajas en sodio, metodos de preparacion, y uso de las mismas. | |
CL2009001686A1 (es) | Procedimiento de preparacion de agomelatina; y los compuestos intermediarios considerados. | |
CR10206A (es) | Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
CR11859A (es) | Composición y proceso-356 | |
CR11132A (es) | Composiciones de aglutinantes no edulcorados y metodos para su preparacion y utilizacion | |
UY32635A (es) | Derivados de bis-(sulfonilamino) en terapia 735 | |
AR069749A1 (es) | Proceso de dehidrohalogenacion para la preparacion de intermediarios utiles en el suministro de compuestos 6,6- dimetil-3-azabiciclo -(3.1.0)- hexano | |
GT200500382A (es) | Sulfonamido-macrociclos y sus sales como inhibidores de tie2, composicion farmaceutica que comprende estos compuestos, metodo de prepararlos y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted | ||
FD | Application lapsed |